Similar articles

• Role of skeletal muscle in the syndrome of chronic heart failure.

  Poole-Wilson PA, Ferrari R. Poole-Wilson PA, et al. J Mol Cell Cardiol. 1996 Nov;28(11):2275-85. doi: 10.1006/jmcc.1996.0220. J Mol Cell Cardiol. 1996. PMID: 8938581 Review. No abstract available.
• Questions in cardiac resynchronization therapy: metabolic implications.

  Karhausen T, Stockburger M, Doehner W, Anker SD. Karhausen T, et al. J Am Coll Cardiol. 2006 Aug 1;48(3):591-2; author reply 592. doi: 10.1016/j.jacc.2006.05.001. Epub 2006 Jul 12. J Am Coll Cardiol. 2006. PMID: 16875992 No abstract available.
• Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.

  George I, Xydas S, Mancini DM, Lamanca J, DiTullio M, Marboe CC, Shane E, Schulman AR, Colley PM, Petrilli CM, Naka Y, Oz MC, Maybaum S. George I, et al. J Heart Lung Transplant. 2006 Sep;25(9):1084-90. doi: 10.1016/j.healun.2006.06.017. J Heart Lung Transplant. 2006. PMID: 16962470 Clinical Trial.
• [Energy, structure, and cardiac insufficiency].

  Karsanov NV. Karsanov NV. Biull Eksp Biol Med. 1999 Aug;127(8):124-40. Biull Eksp Biol Med. 1999. PMID: 11188729 Review. Russian. No abstract available.
• Myofascial force transmission and tendon transfer for patients suffering from spastic paresis: a review and some new observations.

  Smeulders MJ, Kreulen M. Smeulders MJ, et al. J Electromyogr Kinesiol. 2007 Dec;17(6):644-56. doi: 10.1016/j.jelekin.2007.02.002. Epub 2007 Mar 21. J Electromyogr Kinesiol. 2007. PMID: 17369052 Review.